High-Dose IV Vitamin C for Cancer: What the Evidence Says (Trials, Safety, Quality of Life)

18 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
In this MMC Insights Podcast episode, we unpack the “High-Dose IV Vitamin C” conversation in cancer care: what it is, why it’s controversial, and what the research actually shows so far.

You’ll learn how intravenous (IV) vitamin C is theorized to work at high doses (a pro-oxidant effect that can generate hydrogen peroxide / ROS, increasing oxidative stress that may damage cancer cells), plus why researchers often study it as an adjunct (adjuvant) therapy alongside chemotherapy and radiation rather than as a standalone treatment.

We also break down the state of the evidence: a mixed picture across preclinical research and human trials. We’ll cover practical considerations too - risk vs reward, who should be cautious, and why the field still needs larger, high-quality trials to clarify where (and for whom) high-dose IV vitamin C fits in an integrative oncology plan.

Educational only — not medical advice. Always discuss supplements and infusions with your oncology/medical team, especially if you’re in active treatment.

https://meakinmetaboliccare.com/
Categoria
Oncology
Commenta per primo questo video.

Prossimo